772
Atea Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
661
FY23:
590
FY24:
462
FY25:
311
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.49
FY22:
5.79
FY23:
4.51
FY24:
2.31
FY25:
4.23
Total assets
Change from FY21 to FY25
millions USD
FY21:
773
FY22:
667
FY23:
595
FY24:
465
FY25:
315
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
56.9
FY22:
18.5
FY23:
32.4
FY24:
18.6
FY25:
39.8
(negative)
Change from FY21 to FY25
millions USD
FY21:
5.93
FY22:
7.66
FY23:
7.40
FY24:
7.20
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
710
FY22:
641
FY23:
555
FY24:
439
FY25:
275
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
773
FY22:
667
FY23:
595
FY24:
465
FY25:
315
All amounts in millions USD